Showing 1271-1280 of 1969 results for "".
- Dr. Kelly Huang to Obalon; Alisa Lask to Oversee Galderma's Aesthetic & Corrective Business Unithttps://modernaesthetics.com/news/dr-kelly-huang-to-obalon-alisa-lask-to-oversee-galdermas-aesthetic-corrective-business-unit/2472202/Former Galderma general manager Kelly Huang, Ph.D. is now Obalon’s Chief Operating Officer. In this new role, Dr. Huang will be responsible for the key commercial functions of sales, marketing, operations, and quality assurance. In related
- Alma Lasers Inc. Hair Removal Platform Now Comprises Three Wavelengthshttps://modernaesthetics.com/news/alma-lasers-inc-hair-removal-platform-now-comprises-three-wavelengths/2472221/Alma Lasers now offers 1064 Nd: YAG capabilities along with 810nm and 755nm on its Soprano ICE platform, allowing users to better match wavelength to hair removal patient. Alma added Alexandrite technology to its Soprano ICE platform in 2014 for
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://modernaesthetics.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De
- AAD 2026: Allergan Aesthetics Highlights TrenibotE Data and GLP-1 RA Patient Trendshttps://modernaesthetics.com/news/aad-2026-allergan-aesthetics-highlights-trenibote-data-and-glp-1-patient-trends/2486432/Allergan Aesthetics, an AbbVie company, presented four posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, including new findings on repeat treatment with investigational trenibotulinumtoxinE (TrenibotE) and insights into aesthetic trends among patients r
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Aesthetic Sequelae of GLP-1 Receptor Agonists Highlighted in Clinical Reviewhttps://modernaesthetics.com/news/aesthetic-sequelae-of-glp-1-receptor-agonists-highlighted-in-clinical-review/2485615/Dermatologists are increasingly encountering aesthetic complications associated with GLP-1 receptor agonist (RA)–induced weight loss, according to a clinical review presented at the South Beach Symposium. The poster, b
- Injectable Skin Boosters Market Set to Exceed $3.2 Billion by 2032, Driven by HA-Based Rejuvenation Trendshttps://modernaesthetics.com/news/injectable-skin-boosters-market-set-to-exceed-32-billion-by-2032-driven-by-ha-based-rejuvenation-trends/2485495/The global market for injectable skin boosters is projected to more than double over the next decade, climbing from $1,492.17 million in 2025 to an estimated $3,263.80 million by 2032, according to new data from MMR Statistics. This represents a compound annual gro
- ODAC 2026 Adds Hands-On, High-Impact Workshopshttps://modernaesthetics.com/news/odac-2026-adds-hands-on-high-impact-workshops/2484689/The ODAC Dermatology Conference will return to Orlando, Florida, in 2026 with a refreshed slate of interactive, expert-led sessions that emphasize skill-building across medical, surgical, and aesthetic dermatology, organizers said in a press release. Scheduled for J
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://modernaesthetics.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.